395 related articles for article (PubMed ID: 29907092)
1. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.
Westenfield K; Sarafoglou K; Speltz LC; Pierpont EI; Steyermark J; Nascene D; Bower M; Pierpont ME
BMC Med Genet; 2018 Jun; 19(1):100. PubMed ID: 29907092
[TBL] [Abstract][Full Text] [Related]
2. SLC35A2-CDG: novel variants with two ends of the spectrum.
Kasapkara ÇS; Ceylan AC; Özyürek H; Karakaya Molla G; Civelek Ürey B; Kıreker Köylü O; Küçükçongar Yavaş A; Sönmez FM
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1185-1189. PubMed ID: 34161696
[TBL] [Abstract][Full Text] [Related]
3. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.
Vals MA; Ashikov A; Ilves P; Loorits D; Zeng Q; Barone R; Huijben K; Sykut-Cegielska J; Diogo L; Elias AF; Greenwood RS; Grunewald S; van Hasselt PM; van de Kamp JM; Mancini G; Okninska A; Pajusalu S; Rudd PM; Rustad CF; Salvarinova R; de Vries BBA; Wolf NI; ; Ng BG; Freeze HH; Lefeber DJ; Õunap K
J Inherit Metab Dis; 2019 May; 42(3):553-564. PubMed ID: 30746764
[TBL] [Abstract][Full Text] [Related]
4. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation.
Ng BG; Buckingham KJ; Raymond K; Kircher M; Turner EH; He M; Smith JD; Eroshkin A; Szybowska M; Losfeld ME; Chong JX; Kozenko M; Li C; Patterson MC; Gilbert RD; Nickerson DA; Shendure J; Bamshad MJ; ; Freeze HH
Am J Hum Genet; 2013 Apr; 92(4):632-6. PubMed ID: 23561849
[TBL] [Abstract][Full Text] [Related]
5. SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.
Ng BG; Sosicka P; Agadi S; Almannai M; Bacino CA; Barone R; Botto LD; Burton JE; Carlston C; Chung BH; Cohen JS; Coman D; Dipple KM; Dorrani N; Dobyns WB; Elias AF; Epstein L; Gahl WA; Garozzo D; Hammer TB; Haven J; Héron D; Herzog M; Hoganson GE; Hunter JM; Jain M; Juusola J; Lakhani S; Lee H; Lee J; Lewis K; Longo N; Lourenço CM; Mak CCY; McKnight D; Mendelsohn BA; Mignot C; Mirzaa G; Mitchell W; Muhle H; Nelson SF; Olczak M; Palmer CGS; Partikian A; Patterson MC; Pierson TM; Quinonez SC; Regan BM; Ross ME; Guillen Sacoto MJ; Scaglia F; Scheffer IE; Segal D; Singhal NS; Striano P; Sturiale L; Symonds JD; Tang S; Vilain E; Willis M; Wolfe LA; Yang H; Yano S; Powis Z; Suchy SF; Rosenfeld JA; Edmondson AC; Grunewald S; Freeze HH
Hum Mutat; 2019 Jul; 40(7):908-925. PubMed ID: 30817854
[TBL] [Abstract][Full Text] [Related]
6. A case of de novo splice site variant in SLC35A2 showing developmental delays, spastic paraplegia, and delayed myelination.
Miyamoto S; Nakashima M; Ohashi T; Hiraide T; Kurosawa K; Yamamoto T; Takanashi J; Osaka H; Inoue K; Miyazaki T; Wada Y; Okamoto N; Saitsu H
Mol Genet Genomic Med; 2019 Aug; 7(8):e814. PubMed ID: 31231989
[TBL] [Abstract][Full Text] [Related]
7. SLC35A2-related congenital disorder of glycosylation: Defining the phenotype.
Yates TM; Suri M; Desurkar A; Lesca G; Wallgren-Pettersson C; Hammer TB; Raghavan A; Poulat AL; Møller RS; Thuresson AC; Balasubramanian M
Eur J Paediatr Neurol; 2018 Nov; 22(6):1095-1102. PubMed ID: 30194038
[TBL] [Abstract][Full Text] [Related]
8. A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach.
Dörre K; Olczak M; Wada Y; Sosicka P; Grüneberg M; Reunert J; Kurlemann G; Fiedler B; Biskup S; Hörtnagel K; Rust S; Marquardt T
J Inherit Metab Dis; 2015 Sep; 38(5):931-40. PubMed ID: 25778940
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of SLC35A2 gene variants related congenital disorders of glycosylation typeⅡ].
Lang CH; Yang Y; Niu XY; Yang XL; Chen Y; Zhang YH
Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):586-590. PubMed ID: 32605344
[No Abstract] [Full Text] [Related]
10. [Analysis of SLC35A2 gene variant in a child with congenital disorder of glycosylation type IIm].
Li J; Wang W; Zhu Q; Sun J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):989-992. PubMed ID: 34625939
[TBL] [Abstract][Full Text] [Related]
11. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy.
Kimizu T; Takahashi Y; Oboshi T; Horino A; Koike T; Yoshitomi S; Mori T; Yamaguchi T; Ikeda H; Okamoto N; Nakashima M; Saitsu H; Kato M; Matsumoto N; Imai K
Brain Dev; 2017 Mar; 39(3):256-260. PubMed ID: 27743886
[TBL] [Abstract][Full Text] [Related]
12.
Kodríková R; Pakanová Z; Krchňák M; Šedivá M; Šesták S; Květoň F; Beke G; Šalingová A; Skalická K; Brennerová K; Jančová E; Baráth P; Mucha J; Nemčovič M
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831116
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.
Witters P; Tahata S; Barone R; Õunap K; Salvarinova R; Grønborg S; Hoganson G; Scaglia F; Lewis AM; Mori M; Sykut-Cegielska J; Edmondson A; He M; Morava E
Genet Med; 2020 Jun; 22(6):1102-1107. PubMed ID: 32103184
[TBL] [Abstract][Full Text] [Related]
14. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.
Kodera H; Nakamura K; Osaka H; Maegaki Y; Haginoya K; Mizumoto S; Kato M; Okamoto N; Iai M; Kondo Y; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Hayasaka K; Sugahara K; Yuasa I; Wada Y; Matsumoto N; Saitsu H
Hum Mutat; 2013 Dec; 34(12):1708-14. PubMed ID: 24115232
[TBL] [Abstract][Full Text] [Related]
15. Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.
Hamici S; Bastaki F; Khalifa M
Eur J Med Genet; 2017 Oct; 60(10):541-547. PubMed ID: 28778787
[TBL] [Abstract][Full Text] [Related]
16. DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype.
Elsharkawi I; Wongkittichote P; Daniel EJP; Starosta RT; Ueda K; Ng BG; Freeze HH; He M; Shinawi M
J Inherit Metab Dis; 2023 Jan; 46(1):92-100. PubMed ID: 36214423
[TBL] [Abstract][Full Text] [Related]
17. Congenital disorders of glycosylation: The Saudi experience.
Alsubhi S; Alhashem A; Faqeih E; Alfadhel M; Alfaifi A; Altuwaijri W; Alsahli S; Aldhalaan H; Alkuraya FS; Hundallah K; Mahmoud A; Alasmari A; Mutairi FA; Abduraouf H; AlRasheed L; Alshahwan S; Tabarki B
Am J Med Genet A; 2017 Oct; 173(10):2614-2621. PubMed ID: 28742265
[TBL] [Abstract][Full Text] [Related]
18. Congenital disorders of glycosylation with emphasis on cerebellar involvement.
Barone R; Fiumara A; Jaeken J
Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
[TBL] [Abstract][Full Text] [Related]
20. Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE).
Bonduelle T; Hartlieb T; Baldassari S; Sim NS; Kim SH; Kang HC; Kobow K; Coras R; Chipaux M; Dorfmüller G; Adle-Biassette H; Aronica E; Lee JH; Blumcke I; Baulac S
Acta Neuropathol Commun; 2021 Jan; 9(1):3. PubMed ID: 33407896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
